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Abstract 
The number of deaths from asthma in England and Wales has not changed significantly over 
the last decade. This lack of improvement has received attention from both national asthma 
guidelines and the media. We examined asthma death data from the Office for National 
Statistics, stratified by age band. Every 5 year age band below the age of 80 years has seen 
a large reduction in mortality between 2001 and 2017, whereas numbers of asthma deaths 
have increased by 81% for people aged 80 or above. This increase in older people dying from 
asthma requires explanation. 
  
Introduction 
In the UK recent press attention has focussed on how death rates from asthma compare 
unfavourably to the rest of Europe [1]; according to data from Eurostat the number of asthma 
deaths in the UK has increased by more than 20% in five years, with figures from 2015 
showing 1434 people dying from an asthma attack. Attention has also fallen on asthma 
mortality in young people; the UK has the worst mortality rate in people aged 10–24 included, 
and the second highest among 15- to 19-year-olds in European countries [2]. 
  
Conversely a recent paper describes asthma mortality, emergency admissions and 
prevalence as decreasing over recent decades in England, although mortality did appear to 
be related to socioeconomic status with a 19% lower mortality among 5-44 year olds in the 
most deprived quintile compared to those in the least deprived quintile. In older adults this 
trend was reversed [3]. 
  
Methods 
To investigate this apparent discrepancy and explore the age distribution of asthma deaths in 
more detail we examined the raw numbers of deaths from asthma across England and Wales 
in the period 2001-2017 using data from the Office for National Statistics (ONS) which 
compiles data from death certificates using the International Classification of Diseases Version 
10 (ICD-10) codes J45 and J46 for asthma. 
  
Raw data were grouped into 5 year age bands (<1 year, 01-04 years, 05-09 years, 10-14 
years etc.) up to 85-89 and >90 years. In order to explore the possibility of miscoding on 
asthma deaths as a potential issue we also obtained data on 5 year age bands for deaths from 
COPD (Chronic Obstructive Pulmonary Disease) using ICD-10 codes J40-44. To calculate 
and plot annual asthma and COPD mortality rates we used 2011 population data as a 
baseline; 
https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populatione
stimates/datasets/2011censuspopulationandhouseholdestimatesforenglandandwales 
(Accessed 17/5/2019). For ease of presentation, data were split into age related quintiles- 0-
24 years, 25-49 years, 50-74 years and >75 years. 
  
Results 
There was only a 2.5% reduction in asthma deaths in England and Wales from 2001 to 2017 
(see Table 1). However, when stratified by age there was large variation in the change in 
number of deaths over time. For those below the age of 75 years there was a 53% reduction 
in deaths, as compared to a 50% increase in deaths from asthma in people aged over 75 
years. In the same period there was a 22.4% increase in deaths from COPD in people over 
75 years. The trends for death from asthma and COPD in people stratified by age are seen in 
Figures 1 and 2. 
  
Conclusion 
There has been no overall change in the numbers of asthma deaths in England and Wales 
since 2001, however there has been a large drop in deaths in people under the age of 75, with 
a corresponding increase in those aged over 75. There has also been a corresponding rise in 
the number of people dying from COPD. 
  
The cause of such divergent trends based on age in asthma mortality is unclear. The 
difference may reflect disease chronicity with airway remodelling and consequent reduced 
response to bronchodilators in older people. Older people can also be more sensitive to side 
effects from beta adrenergic agonists and glucocorticoids, especially in the face of 
polypharmacy, and many have difficulty using inhalers correctly [4]. There is evidence that 
asthma exacerbation rates are higher in the older age groups [5] and although anecdotally it 
is recognised that people who develop asthma at an older age may have a worse outcome 
[6], an older age of onset of asthma does not appear to be associated with higher exacerbation 
rates [7]. 
  
The differential mortality rates after stratification by age may reflect the misattribution of the 
cause of death as asthma rather than as a different respiratory disease such as COPD; we 
also collected data on COPD deaths and a similar increase was observed above and the age 
of 75 years. 
  
The potential issue of miscoding was flagged in the National Review of Asthma Deaths 
(NRAD) [8], where 514/1414 (36%) of the deaths in the 12 months from February 2011 with 
asthma in part II of the Medical Certificate Cause of Death (MCCD) were possibly erroneously 
classified as J459; i.e. deaths due to asthma. Complex rules applied by the World Health 
Organisation for classifying diseases in order to determine the underlying cause of death 
based on death certificates can result in considerable variation in the subsequent assignment 
of the cause of death. However it is still important to note that most of the deaths from asthma 
examined in NRAD were thought to be preventable. 
  
Whatever the reason for the apparent age difference in mortality more research is needed into 
this rise in deaths from asthma in the older population. This is particularly pertinent as it is 
estimated that many elderly patients with asthma are treated with drugs that have not been 
tested in older populations and that older people with asthma are often excluded from clinical 
studies because of age based inclusion criteria and co-morbidities; one study found the odds 
ratio of being excluded from RCTs increased to 18.6 at the age of 75–84 years when compared 
to the youngest populations [9]. 
  
In summary the stable rate of asthma deaths seen over the last 18 years hides significant 
differences related to age. The apparent increase in deaths from asthma in an older population 
needs explanation if we are to improve asthma outcomes in the context of an ageing 
population. 
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Table 1 
Numbers of death from asthma or COPD in 2001 and 2017 in England and Wales 
  
                             
 
 
                              Asthma Deaths                                                    COPD Deaths 
Age Band 
(years) 
2001 2017 % change   2001 2017 % change 
0-24 48 18 -62.5   8 5 -37.5 
25-49 137 51 -62.8   163 181 +11 
50-74 459 234 -49   8113 9063 +11.7 
>75 620 930 +50   16120 19814 +22.4 
Total 1264 1233 -2.5   24404 29063 +19.1 
  
  
  
  
Figure 1 Asthma Mortality (deaths/1000 population), 2001 to 2017 in England and Wales 
  
Figure 2 COPD Mortality (deaths/1000 population), 2001 to 2017 in England and Wales 
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